FIELD: medicine.
SUBSTANCE: invention relates to a compound represented by the chemical formula 1 or its pharmaceutically acceptable salt, where R1 is hydrogen, R2 is fluor or C1-C4 alkyl composite ester, and R3 is structures (a), (b), (c) or (d). the invention also relates to a pharmaceutical composition for the prevention or treatment of a disease associated with the inhibition of FLT3 kinase containing (a) effective amount of the compound represented by the chemical formula 1 or its pharmaceutically acceptable salt; and (b) a pharmaceutically acceptable carrier.
EFFECT: obtaining compounds having inhibiting capability relatively to FLT3.
formula 1,
(а),
(b), 
(c), 
(d)
5 cl, 4 tbl, 6 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF 2-IMINOPYRROLIDINE | 2002 |
|
RU2270192C2 |
| SIGMA-RECEPTOR INHIBITORS | 2005 |
|
RU2417987C2 |
| NOVEL TRICYCLIC DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAID DERIVATIVE | 2009 |
|
RU2470934C1 |
| PYRROLO-PYRIDINE COMPOUND DERIVATIVE, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING AND TREATING PROTEIN KINASE RELATED DISEASES | 2018 |
|
RU2730849C1 |
| 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5-HT3 MODULATORS | 2007 |
|
RU2448105C2 |
| DERIVATIVES OF 2-SUBSTITUTED PHENYL-5,7-DIHYDROCARBYL-3,7-DIHYDROPYRROLO[2,3-d]PYRIMIDIN-4-ONES, THEIR PREPARING AND PHARMACEUTICAL USING | 2004 |
|
RU2323220C2 |
| DIAMINOHETEROCYCLIC CARBOXAMIDE COMPOUND | 2010 |
|
RU2526253C2 |
| PYRAZOLE DERIVATIVES APPLIED AS PROTEIN KINASE INHIBITORS | 2013 |
|
RU2623221C2 |
| HYDROXYBENZAMIDE DERIVATIVES AND USE THEREOF AS Hsp90 INHIBITORS | 2006 |
|
RU2458919C2 |
| SUBSTITUTED PYRAZOLO-QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS | 2011 |
|
RU2652638C2 |
